Regulatory transcriptional networks orchestrating mouse pluripotent embryonic stem cells
The lack of a quantitative framework around the dynamics of gene expression and its determinants represents a major hurdle for capturing transcription regulation into regulatory models. Embryonic Stem Cells (ESC) provide an excell...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SPLICE-STEM
Identification of alternative splicing networks defining emb...
100K€
Cerrado
OCTOBER
Control of cell identity in pluripotent and germline cells b...
213K€
Cerrado
EFIMB
Esrrb Function in Mitotic Bookmarking
194K€
Cerrado
GRNES
Analysis of the gene regulatory network controlling ES cell...
181K€
Cerrado
CELLREPROGRAMMING
Uncovering the Mechanisms of Epigenetic Reprogramming of Plu...
2M€
Cerrado
BFU2014-55076-P
REGULACION DEL DESARROLLO EMBRIONARIO TEMPRANO Y PLURIPOTENC...
218K€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The lack of a quantitative framework around the dynamics of gene expression and its determinants represents a major hurdle for capturing transcription regulation into regulatory models. Embryonic Stem Cells (ESC) provide an excellent cellular model to quantitatively define the principles of gene regulation at the biochemical and (epi)genetic level. In SysStemCell, I will focus on two distinct mouse pluripotent cell states. My recent studies have shown that the epigenome and transcriptome of ESCs maintained in serum-free medium complemented with two kinase inhibitors and LIF (‘2i ESC’) are distinct from classical ESCs cultured in the presence of serum and LIF (‘serum ESC’). Importantly, the 2i ESCs reflect pre-implantation stage ICM cells whereas the widely studied serum cells reflect post-implantation ESCs. These two distinct pluripotent states are interconvertible in vitro, providing an unique and accessible model to explore the regulation of the pre- to post-implantation phase of early embryonic development. I will combine state-of-the-art proteomics and chromatin-based methods, including a novel in vivo UV femtosecond laser crosslinking approach, and in depths bioinformatics in an iterative manner to define the full compendium of transcription (co)factors (TF) and TF-modules that define the two cell states. The dynamics of long- and short-range interactions between these modules will be assessed and correlated with the epigenetic state and chromatin structure. Novel and existing factors will be assessed for their role in differentiation from 2i to serum and reverse programming using knockout and forced expression strategies. Collectively, my studies will provide an invaluable resource for the community and a deep insight in the mechanisms and general principles that orchestrate gene expression in particular in the hitherto unexplored transition at implantation during early mouse development.